[{"NetIncomeLoss_3_Q3_USD":-142072777.0,"Depreciation_3_Q3_USD":2323505.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-55079630.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":9700000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-247834.0,"PaymentsToAcquireShortTermInvestments_3_Q3_USD":153135274.0,"InterestPaidNet_3_Q3_USD":4614662.0,"EquitySecuritiesFvNiUnrealizedGain_3_Q3_USD":624522.0,"InterestIncomeOperating_1_Q3_USD":896710.0,"ProceedsFromSaleOfShortTermInvestments_3_Q3_USD":61263665.0,"InterestIncomeOperating_3_Q3_USD":2380678.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3_Q3_USD":-1063757.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q3_USD":493000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":10110506.0,"GeneralAndAdministrativeExpense_3_Q3_USD":28630370.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q3_USD":0.0,"NetIncomeLossAttributableToNoncontrollingInterest_3_Q3_USD":-1063757.0,"OperatingLeaseLiability_0_Q3_USD":20934000.0,"EquityMethodInvestments_0_Q3_USD":957567.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q3_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":356012.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":1157214.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":23533298.0,"GoodwillGross_0_Q3_USD":10513371.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":329960855.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":13008571.0,"ShareBasedCompensation_3_Q3_USD":11822483.0,"Assets_0_Q3_USD":437814047.0,"IncreaseDecreaseInAccountsReceivableRelatedParties_3_Q3_USD":-846894.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":158535744.0,"ProceedsFromMinorityShareholders_3_Q3_USD":2379969.0,"CommonStockSharesIssued_0_Q3_shares":167528435.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":4045000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":-1695051.0,"DueToRelatedPartiesCurrent_0_Q3_USD":794928.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":12171771.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":24592948.0,"ProceedsFromIssuanceOfLongTermDebt_3_Q3_USD":0.0,"AssetsCurrent_0_Q3_USD":377064673.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":4023000.0,"EquitySecuritiesFvNi_0_Q3_USD":4154049.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-726626.0,"IncreaseDecreaseInOtherAccruedLiabilities_3_Q3_USD":198761.0,"EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_1_Q3_USD":35306000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-136644.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-714246.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":148656454.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":174376402.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q3_USD":1315980.0,"EquitySecuritiesFvNiUnrealizedGainLoss_3_Q3_USD":624522.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":6184.0,"MinorityInterest_0_Q3_USD":96269.0,"AccountsReceivableNetCurrent_0_Q3_USD":7692944.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q3_USD":520000.0,"EarningsPerShareBasic_3_Q3_USD":-0.96,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":7190221.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":28973000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":26455112.0,"ResearchAndDevelopmentExpense_3_Q3_USD":67942875.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":985000.0,"ShortTermInvestments_0_Q3_USD":158535744.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-33115.0,"EarningsPerShareBasic_1_Q3_USD":0.12,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"CommonStockValue_0_Q3_USD":167527.0,"EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_3_Q3_USD":-75670977.0,"GainLossOnInvestments_3_Q3_USD":-571778.0,"Liabilities_0_Q3_USD":113813932.0,"DebtSecuritiesAvailableForSaleRealizedLoss_1_Q3_USD":101000.0,"DebtSecuritiesAvailableForSaleRealizedLoss_3_Q3_USD":1300000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":18669643.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":178700434.0,"OtherAssetsNoncurrent_0_Q3_USD":17641755.0,"AmortizationOfIntangibleAssets_1_Q3_USD":137000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":410311.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":19533532.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-142793219.0,"ProceedsFromNotesPayable_3_Q3_USD":171620.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":337200000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":338340340.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_3_Q3_USD":-75670977.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":290602.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":5383268.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q3_investment":11.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":6.78,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":19533532.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q3_USD":12.09,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":3001000.0,"PaymentsForProceedsFromInvestments_3_Q3_USD":-40125418.0,"LiabilitiesCurrent_0_Q3_USD":41263167.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":3968000.0,"DeconsolidationGainOrLossAmount_1_Q3_USD":0.0,"DeconsolidationGainOrLossAmount_3_Q3_USD":4121075.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":165355540.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":148656454.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-126762557.0,"PaymentsOfDebtIssuanceCosts_3_Q3_USD":0.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":6184.0,"IncreaseDecreaseInAccountsPayableRelatedParties_3_Q3_USD":287609.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":4158495.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":4028177.0,"Goodwill_0_Q3_USD":10513371.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":1785532.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q3_USD":276000.0,"DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_1_Q3_USD":0.0,"DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_3_Q3_USD":0.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":6184.0,"IncomeLossFromEquityMethodInvestments_1_Q3_USD":-1759674.0,"InterestExpense_3_Q3_USD":7634442.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":178700434.0,"NetIncomeLoss_1_Q3_USD":19171336.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":11190521.0,"DebtSecuritiesAvailableForSaleRealizedGain_3_Q3_USD":741000.0,"DebtSecuritiesAvailableForSaleRealizedGain_1_Q3_USD":105000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":32046.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":3283540.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":324000115.0,"AdditionalPaidInCapital_0_Q3_USD":1205842585.0,"InterestExpense_1_Q3_USD":1984046.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q3_USD":19171336.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q3_shares":9020862.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_3_Q3_shares":0.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":14969731.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_0_Q3_investment":0.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.084,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":3283540.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":9856073.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":31563697.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_3_Q3_USD":-142072777.0,"IncomeLossFromEquityMethodInvestments_3_Q3_USD":-2661431.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q3_USD":4000.0,"ContractWithCustomerLiabilityRevenueRecognized_3_Q3_USD":127000.0,"OperatingExpenses_3_Q3_USD":96573245.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q3_USD":137000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":2264261.0,"DerivativeLiabilities_0_Q3_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":437814047.0,"PreferredStockValue_0_Q3_USD":0.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":10473761.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":77878.0,"OperatingExpenses_1_Q3_USD":36565618.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_3_Q3_USD":84490000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q3_USD":20931010.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3_Q3_USD":-140475103.0,"OperatingIncomeLoss_1_Q3_USD":-36329440.0,"OperatingIncomeLoss_3_Q3_USD":-94742606.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":236178.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":1830639.0,"CommonStockSharesAuthorized_0_Q3_shares":600000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":30055813.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q3_USD":0.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":0.0,"Capital_0_Q3_USD":335800000.0,"ProfitLoss_3_Q3_USD":-143136534.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q3_USD":253000.0,"IncreaseDecreaseInDerivativeLiabilities_3_Q3_USD":75670977.0,"EarningsPerShareDiluted_3_Q3_USD":-0.96,"EarningsPerShareDiluted_1_Q3_USD":0.11,"CommonStockSharesOutstanding_0_Q3_shares":167528435.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":6992871.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":156504337.0,"LeaseCost_1_Q3_USD":836000.0,"LeaseCost_3_Q3_USD":2500000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-881858432.0,"CashDivestedFromDeconsolidation_3_Q3_USD":2774851.0,"AccountsReceivableRelatedPartiesCurrent_0_Q3_USD":501311.0,"IncreaseDecreaseInOtherOperatingLiabilities_3_Q3_USD":2833.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":157907426.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":558588.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":82927.0,"StockholdersEquity_0_Q3_USD":323903846.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":39776.0,"ProfitLoss_1_Q3_USD":19171336.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":8039000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":-143856976.0,"Ticker":"INO","CIK":"1055726","name":"INOVIO PHARMACEUTICALS, INC.","OfficialName":"Inovio Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"674206680.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20201109"}]